Bill

Bill > H1713


MA H1713

Requiring practitioners to assess and inform patients prior to prescribing certain opioid medications


summary

Introduced
01/22/2019
In Committee
01/22/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

Relative to requiring practitioners to assess and inform patients prior to prescribing certain opioid medications. Mental Health, Substance Use and Recovery.

AI Summary

This bill requires practitioners to assess and inform patients prior to prescribing certain opioid medications. Specifically, before issuing an extended-release long-acting opioid in a non-abuse deterrent form for outpatient use for the first time, practitioners must: (1) evaluate the patient's current condition, risk factors, and history of mental health or substance use disorders; (2) discuss the risks of addiction, overdose, and concurrent use of alcohol or other central nervous system depressants with the patient and, if the patient is a minor, the patient's parent or legal guardian; (3) inform the patient and, if applicable, the patient's parent or legal guardian that the prescribed medication is an appropriate course of treatment based on the medical need of the patient; and (4) obtain the patient's (and, if applicable, the patient's parent or legal guardian's) written informed consent on a form established by the department.

Committee Categories

Health and Social Services

Sponsors (6)

Last Action

Accompanied a new draft, see H4533 (on 03/09/2020)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...